Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery

Journal of Orthopaedic Science

Volumn 16, Issue 1, 2011, Pages 64-70

  Sasaki, Satoshi ^a   Miyakoshi, Naohisa ^b   Matsuura, Hiroshi ^a   Saito, Hidetomo ^b   Nakanishi, Toru ^a   Kudo, Yumiko ^a   Fujiya, Tomiko ^a   Shimada, Yoichi ^b  

^a Yuri Kumiai General Hospital   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; CREXINE; D DIMER; ENOXAPARIN; FONDAPARINUX; HEPARIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLEEDING; COMPRESSION GARMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HIP ARTHROPLASTY; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; JAPANESE; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROSPECTIVE STUDY; TREATMENT OUTCOME; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 79953298743     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-010-0011-5     Document Type: Article

References (24)

1. Geerts WH, Bergquist D, Pineo GF, Heit JA, Samama CF, Lassen MR, Colwell CW. Prevention of venous thromboembolism. American College of Chest Physicians evidence-based clinical guidelines (8th edition). Chest. 2008;133:381S-453S.
2. Eriksson BI, Bauer KA, Lassen MR, Turpie AGG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345:1298-304.
3. Eriksson BI, Lassen MR. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery. A multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2003;163:1337-42.
4. Bauer KA, Eriksson BI, Lassen MR, Turpie AGG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001;345:1305-10.
5. Lassen MR, Bauer KA, Eriksson BI, Turpie AGG. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet. 2002;359:1715-20. (Pubitemid 34607083)
6. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet. 2002;359:1721-6. (Pubitemid 34607085)
7. Fuji T, Fujita S. Efficacy and safety of fondaparinux sodium for the prevention of venous thromboembolism after hip-fracture surgery. Kossetsu (Fracture). 2008;30:206-9 (in Japanese).
8. Fuji T, Fujita S. Efficacy and safety of enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. Hip Joint. 2008;34:679-82 (in Japanese).
9. Sasaki S, Miyakoshi N, Matsuura H, Saitoh H, Kudoh D, Shimada Y. Prospective randomized controlled trial on the effect of fondaparinux sodium for the prevention of venous thromboembolism after hip fracture surgery. J Orthop Sci. 2009;14:491-6.
10. Bongard O, Wicky J, Peter R, Simonovska S, Vogel JJ, Moerloose P, Bounameaux H. D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res. 1994;74:487-93.
11. Peetz D, Hafner G, Hansen M, Mayer A, Rippin G, Rommens PM, Prellwitz W. Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-dimer. Thromb Res. 2000;98:473-83. (Pubitemid 30433775)
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
13. Turpie AGG, Gallus AS, Hoek JA. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med. 2001;344:619-25. (Pubitemid 32183576)
14. Hirsh J, Levine MN. Low molecular weight heparin. Blood. 1992;79:1-17.
15. Turpie AGG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315:925-9. (Pubitemid 16023679)
16. Barsotti J, Gruel Y, Rosset P, Favard L, Dabo B, Andreu J, Delahousse B, Leroy J. Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur. J Orthop Trauma. 1990;4:371-5.
17. Thaler HW, Roller RE, Greiner N, Sim E, Korninger C. Thromboprophylaxis with 60 mg enoxaparin is safe in hip trauma surgery. J Trauma. 2001;51:518-21. (Pubitemid 33009637)
18. Kim T, Murakami T, Hori M, Kumano S, Sakon M, Nakamura H. Efficacy of multi-slice helical CT venography for the diagnosis of deep vein thrombosis: comparison with venous sonography. Radiat Med. 2004;22:77-81. (Pubitemid 38660921)
19. Lensing AWA, Prandoni P, Büller HR, Casara D, Cogo A, Cate JWT. Lower extremity venography with iohexol: results and complications. Radiology. 1990;177:503-5. (Pubitemid 20374874)
20. Pedersen OM, Aslaksen A, Vik-Mo H, Bassoe AM. Compression ultrasonography in hospitalized patients with suspected deep venous thrombosis. Arch Intern Med. 1991;151:2217-20.
21. Shiota N, Satoh T, Matsuo M, Kajiya M, Sakata K, Inoue H. A study of postoperative deep-vein thrombosis in proximal femoral fracture. Rinsho Seikeigeka (Clin Orthop Surg). 2003;38:593-9 (in Japanese).
22. Quinlan DJ, Alikhan RA, Gishen P, Sidhu PS. Variations in lower limb venous anatomy: implications for US diagnosis of deep vein thrombosis. Radiology. 2003;228:443-8. (Pubitemid 36910085)
23. Perrier A, Desmarais S, Miron MJ, Moerloose P, Lepage R, Slosman D, Didier D, Unger PF, Patenaude JV, Bounameaux H. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999;353:190-5. (Pubitemid 29088030)
24. Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci. 2008;13:442-51.